Sanofi presents positive results from DISCOVER phase 4 study of Dupixent in atopic dermatitis patients with skin of colour at 2025 RAD conference: Paris Tuesday, June 10, 2025, 16 ...

Background: Atopic dermatitis (AD) is a common recurrent chronic inflammatory skin disease, and there is increasing evidence of a possible association between AD and autoimmune diseases. Objectives: ...

The atopic dermatitis app will launch first in the UK, followed by Belgium, Norway, the Netherlands, Sweden, France, Ireland, and Japan later in 2022. Image Phil Taylor ...

The approval comes at a critical time: approximately 6% of adolescents within this newly approved age group suffer from atopic dermatitis in the UK. In other words, one in five children.

May be associated with atopic patients. Often worse with each subsequent exposure. Urticaria, erythema, edema, pruritus, classic "wheal and flare." Allergic contact dermatitis 24-48 h 4-10 d ...

EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respirator ...

Allergic contact dermatitis (ACD) due to topical antibiotics is very common. Neomycin and bacitracin are in the top ten most common allergens to cause allergic contact dermatitis. These allergens ...

GATA-binding protein 3 (GATA3) is a zinc-finger transcription factor that is continually expressed in a highly regulated manner throughout T-cell development and CD4 + T helper (T H)-cell ...

Celiac disease can cause a person to develop an itchy, blistering rash on their skin, known as dermatitis herpetiformis. Following a gluten-free diet typically resolves symptoms of a celiac ...